Ethnic variability of HIF-1α polymorphisms

Cancer Biomarkers

Volumn 5, Issue 6, 2009, Pages 273-277

  Ribeiro, A L ^a   Correia, J ^a   Ribeiro, V ^a  

^a UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

Cancer; Ethnic; Hypoxia; Polymorphisms

Indexed keywords

GENOMIC DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; CHILD; COLOMBIA; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENOTYPE; GUINEA-BISSAU; HUMAN; MALE; MOZAMBIQUE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PORTUGAL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; COLOMBIA; ETHNIC GROUPS; FEMALE; GENETIC VARIATION; GUINEA-BISSAU; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MOZAMBIQUE; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; PREVALENCE;

EID: 76749153450     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2009-0112     Document Type: Article

References (43)

1. S.P. Rivera et al., A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia, J Biol Chem 282(15) (2007), 10881-10893.
2. P.H. Maxwell et al., The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature 399(6733) (1999), 271-275.
3. L.E. Huang et al., Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway, Proc Natl Acad Sci USA 95(14) (1998), 7987-7992.
4. L.E. Huang et al., Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit, J Biol Chem 271(50) (1996), 32253-32259.
5. N. Masson et al., Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation, Embo J 20(18) (2001), 5197-5206.
6. J.W. Jeong et al., Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation, Cell 111(5) (2002), 709-720.
7. D. Lando et al., Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch, Science 295(5556) (2002), 858-861.
8. N. Sang et al., Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel- Lindau protein-independent, hydroxylation-regulated association with p300/CBP, Mol Cell Biol 22(9) (2002), 2984-2992.
9. M.I. Koukourakis et al., Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis, Cancer Sci 97(10) (2006), 1056-1060.
10. H. Zhong et al., Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases, Cancer Res 59(22) (1999), 5830-5835.
11. K.L. Talks et al., The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages, Am J Pathol 157(2) (2000), 411-421.
12. R. Bos et al., Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis, J Natl Cancer Inst 93(4) (2001), 309-314.
13. M.I. Koukourakis et al., Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy, Cancer Res 61(5) (2001), 1830-1832.
14. C. Tzao et al., Expression of hypoxia-inducible factor (HIF)- 1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma, Dis Markers 25(3) (2008), 141-148.
15. G.L. Semenza, Targeting HIF-1 for cancer therapy, Nat Rev Cancer 3(10) (2003), 721-732.
16. K. Tanimoto et al., Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance, Carcinogenesis 24(11) (2003), 1779-1783.
17. M.I. Koukourakis et al., C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF- 1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer, Lung Cancer 53(3) (2006), 257-262.
18. C. Hebert et al., Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers, Mol Cancer 5 (2006), 3.
19. M. Ollerenshaw et al., Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype, Cancer Genet Cytogenet 153(2) (2004), 122-126.
20. C.H. Chau et al., Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen independent prostate cancer, Cancer Biol Ther 4(11) (2005), 1222-1225.
21. K. Fransen et al., Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients, Mol Carcinog 45(11) (2006), 833-840.
22. T. Kuwai et al., Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma, Oncol Rep 12(5) (2004), 1033-1037.
23. M.F. Munoz-Guerra et al., Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer, Ann Surg Oncol 16(8) (2009), 2351-2358.
24. E. Konac et al., An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers, Cancer Detect Prev 31(2) (2007), 102-109.
25. I. Cavaco et al., CYP3A4 and MDR1 alleles in a Portuguese population, Clin Chem Lab Med 41(10) (2003), 1345-1350.
26. I. Cavaco et al., CYP3A4*1B and NAT2*14 alleles in a native African population, Clin Chem Lab Med 41(4) (2003), 606-609.
27. N. Fernandes et al., Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant, Malar J 6 (2007), 35.
28. P.S. Walsh, D.A. Metzger and R. Higuchi, Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material, Biotechniques 10(4) (1991), 506-513.
29. N. Yamada et al., Genetic variation in the hypoxia-inducible factor-1alpha gene is associated with type 2 diabetes in Japanese, J Clin Endocrinol Metab 90(10) (2005), 5841-5847. (Pubitemid 41415501)
30. J.Y. Lee et al., Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women, Clin Chim Acta 389(1-2) (2008), 167-170.
31. T.S. Ling et al., Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma, Chin J Dig Dis 6(4) (2005), 155-158.
32. J.R. Resar et al., Hypoxia-inducible factor 1alpha polymorphism and coronary collaterals in patients with ischemic heart disease, Chest 128(2) (2005), 787-791.
33. N.J. Beasley et al., Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients, Cancer Res 62(9) (2002), 2493-2497.
34. D.M. Aebersold et al., Expression of hypoxia-inducible factor- 1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer, Cancer Res 61(7) (2001), 2911-2916.
35. G. Sirugo et al., Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics, Hum Genet 123(6) (2008), 557-598.
36. A. Fregene and L.A. Newman, Breast cancer in sub-Saharan Africa: howdoes it relate to breast cancer in African-American women? Cancer 103(8) (2005), 1540-1550.
37. F.O. Ademuyiwa and O.I. Olopade, Racial differences in genetic factors associated with breast cancer, Cancer Metastasis Rev 22(1) (2003), 47-53.
38. S. Evans et al., Investigating Black-White differences in prostate cancer prognosis: A systematic review and metaanalysis, Int J Cancer 123(2) (2008), 430-435.
39. I. Apaydin et al., Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer, Arch Med Res 39(3) (2008), 338-345.
40. M.J. Percy et al., A common polymorphism in the oxygendependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation, Mol Cancer 2 (2003), 31.
41. M.A. Hlatky et al., Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease, Am Heart J 154(6) (2007), 1035-1042.
42. K. Liu et al., [Association between polymorphisms of HIF- 1alpha C1772T and G1790A and hypoxic acclimation in high altitude in Tibetans], Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 24(3) (2007), 654-658.
43. J. Nadaoka et al., Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder, Int J Cancer 122(6) (2008), 1297-1302.